CLINICAL_TRIALS
trial_result
· 2022-09-06
Clinical Trial Update: Brain Perfusion & Oxygenation in Parkinson's Disease With NOH [Phase 4]
Summary
Phase 4 trial update on brain perfusion and oxygenation in Parkinson's disease with neurogenic orthostatic hypotension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: William Ondo, MD | Conditions: Parkinson Disease, Neurogenic Orthostatic Hypotension | Phase 4 | Status: COMPLETED